These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1292684)

  • 1. [The competition of serum amyloid protein and apoprotein E for binding with human serum albumin].
    Dergunov AD
    Biull Eksp Biol Med; 1992 Dec; 114(12):598-600. PubMed ID: 1292684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of serum albumin with apoprotein E and very low density lipoproteins in human blood].
    Dergunov AD; Vorotnikova IuIu
    Biokhimiia; 1993 Jun; 58(6):944-52. PubMed ID: 8364117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of human serum albumin in the native and fully reduced states with apolipoprotein E, serum amyloid protein and very low density lipoproteins from human plasma.
    Dergunov AD; Vorotnikova YY
    Int J Biochem; 1994 Jul; 26(7):933-42. PubMed ID: 8063017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of prostaglandin E2 with human serum albumin].
    Buko VU; Zavodnik IB; Stepuro II
    Biokhimiia; 1987 Jun; 52(6):891-5. PubMed ID: 3478094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A (SAA) protein-interaction with itself and serum albumin.
    Rosenthal CJ; Franklin EC
    J Immunol; 1977 Aug; 119(2):630-4. PubMed ID: 301900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examination of the protein binding of lidocaine by gel filtration method].
    Kakinohana O; Okuda Y
    Masui; 1993 Oct; 42(10):1488-96. PubMed ID: 8230702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening, purification, and identification of a copper-dependent FITC-binding protein in human plasma: albumin.
    Wu YW; Chen SF; Yang CB; Tsai YH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):187-91. PubMed ID: 18255362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted protein quantitation and profiling using PVDF affinity probe and MALDI-TOF MS.
    Chen SH; Liao HK; Chang CY; Juo CG; Chen JH; Chan SI; Chen YJ
    Proteomics; 2007 Sep; 7(17):3038-50. PubMed ID: 17676666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitogenic activity of type III bacterial Ig binding proteins (protein G) for human peripheral blood lymphocytes is not related to their ability to react with human serum albumin or IgG.
    Otten RA; Boyle MD
    J Immunol; 1991 Apr; 146(8):2588-95. PubMed ID: 2016519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of human serum amyloid P-component to phosphocholine.
    Christner RB; Mortensen RF
    Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental analysis of embichin interaction with human serum albumin].
    Luik AI; Novikova NV
    Farmakol Toksikol; 1980; 43(5):593-7. PubMed ID: 7449990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum.
    Marhaug G; Husby G
    Clin Exp Immunol; 1981 Jul; 45(1):97-106. PubMed ID: 7307348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein.
    Li XA; Yutani C; Shimokado K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):249-52. PubMed ID: 9514915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin-sepharose affinity chromatography and reduction conditions as a method of a selective process for separate isoforms of apolipoprotein A].
    Dergunov AD; Aniskovich LP; Shuvaev VV
    Biull Eksp Biol Med; 1990 Jul; 110(7):42-5. PubMed ID: 2224097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils.
    Caspi D; Baltz ML; Feinstein A; Munn EA; Pepys MB
    Clin Exp Immunol; 1984 Sep; 57(3):647-56. PubMed ID: 6467683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of histamine on dimedrol interaction with human serum albumin].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1985; 48(2):107-12. PubMed ID: 3996563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum amyloid P component binds to a specific peptide in the presence of calcium.
    Hamazaki H
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1172-8. PubMed ID: 7802647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes.
    Brown MR; Anderson BE
    J Immunol; 1993 Aug; 151(4):2087-95. PubMed ID: 8393897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.